ORIC Pharmaceuticals, Inc. ( ORIC) - Stock Earnings
ORIC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
ORIC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -30.5 million USD | — USD |
| 2026Q1 | -35.8 million USD | — USD |
| 2026Q2 | -41.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ORIC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -100.7 million USD | — USD |
| 2024 | -127.8 million USD | — USD |
| 2025 | -129.5 million USD | — USD |
| 2026 Est. | — | — |
ORIC
Price: $12.77
52 week price:
Earnings Per Share: -1.25 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 145300
Market Capitalization: 1.3 billion